Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium.

Rakan NasreddineEric FlorenceJean Cyr YombiSophie HenrardGilles Darcis Jens Tomas Van PraetLinos VandekerckhoveSabine D AllardRémy DemeesterPeter MessiaenNathalie AusseletMarc DelforgeStéphane De Witnull null

Published in: HIV medicine (2023)

In this large real-world cohort, BIC/FTC/TAF showed excellent virological efficacy in a diverse population of patients with HIV. Rare occurrence of emergent drug resistance was observed, and treatment was well tolerated.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
hepatitis c virus
hiv testing
hiv aids
risk assessment
men who have sex with men
hiv infected patients
randomized controlled trial
open label
clinical trial